FrancophonIA/ELRC3.0 huggingface dataset:
English: Finished product: 36 months After first opening: 4 months
Croatian: Nakon prvog otvaranja: 4 mjeseca
English: A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour.
Croatian: Metaanaliza randomiziranih placebom kontroliranih studija antiepileptičkih lijekova pokazala je mali porast rizika samoubilačkih misli i ponašanja.
English: Do not take macrogol (a drug used as laxative) for one hour before and one hour after taking levetiracetam as this may results in a reduction of its effect.
Croatian: Ne uzimajte makrogol (lijek koji se koristi kao laksativ) jedan sat prije i jedan sat nakon uzimanja levetiracetama jer to može smanjiti učinak levetiracetama.
English: The daily dose is administered in two equally divided doses.
Croatian: Dnevna doza primjenjuje se podijeljeno u dvije jednake doze.
English: • Empty the contents of the syringe in a glass of water by pushing the piston into the syringe (figure ).
Croatian: • Ispraznite sadržaj štcaljke u čašu vode potiskivanjem klipa u štrcaljku (slika ).
English: UNIQUE IDENTIFIER - HUMAN READABLE DATA In case no outer packaging is used
Croatian: JEDINSTVENI IDENTIFIKATOR - PODACI ČITLJIVI LJUDSKIM OKOM U slučaju da nije korišteno vanjsko pakiranje
English: When you will first start taking Levetiracetam ratiopharm, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose.
Croatian: Kada prvi put počnete uzimati Levetiracetam ratiopharm, liječnik će Vam propisati manju dozu tijekom 2 tjedna prije davanja najmanje uobičajene doze.
English: Date of first authorisation: 26 August 2011 Date of latest renewal: 28.
Croatian: Datum prvog odobrenja: 26. kolovoza 2011.
English: • Hold bottle and syringe securely tight.
Croatian: • Čvrsto držite bočicu i štrcaljku.
English: Infants and children (1 month to 4 years)
Croatian: Dojenčad i djeca (1 mjeseca do 4 godine)
English: (figure )
Croatian: (slika )
English: What Levetiracetam ratiopharm is and what it is used for
Croatian: Što je Levetiracetam ratiopharm i za što se koristi
English: The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily.
Croatian: Početna doza za dijete ili adolescenta od 25 kg treba biti 250 mg dva puta na dan uz maksimalnu dozu od 750 mg dva puta na na dan.
English: Results related to behavioural and emotional functioning indicated a worsening in levetiracetam treated patients on aggressive behaviour as measured in a standardised and systematic way using a validated instrument (CBCL - Achenbach Child Behavior Checklist).
Croatian: Rezultati ocjene funkcioniranja ponašanja i emocionalnog funkcioniranja uputili su na pogoršanje u smislu agresivnijeg ponašanja u skupini koja je uzimala levetiracetam, ocijenjenog na standardiziran i sistematičan način koristeći validirani instrument (CBCL - Achenbach Child Behavior Checklist).
English: Should your doctor decide to stop your Levetiracetam ratiopharm treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam ratiopharm.
Croatian: Ako Vaš liječnik odluči prekinuti liječenje Levetiracetamom ratiopharm, uputit će Vas kako postupno prekinuti liječenje Levetiracetamom ratiopharm.
English: Do not use after 4 months of first opening the bottle.
Croatian: Nemojte koristiti nakon isteka 4 mjeseca od prvog otvaranja boce.
English: (2) Dose in children and adolescents 50 kg or more is the same as in adults.
Croatian: (2) Doza u djece i adolescenata od 50 kg ili više jednaka je kao u odraslih.
English: • Move bottle and the filled syringe back in starting position.
Croatian: • Vratite bočicu i štrcaljku u početni položaj.
English: Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizure with or without secondary generalisation).
Croatian: Levetiracetam se koristi za oblik epilepsije u kojem napadaji započinju u jednoj strani mozga, ali se nakon toga mogu proširiti na veće područje u obje strane mozga
English: The adverse reaction profile presented below is based on the analysis of pooled placebo-controlled clinical trials with all indications studied, with a total of 3,416 patients treated with levetiracetam.
Croatian: Profil nuspojava opisan niže temelji se na analizi zbirnih placebom konroliranih kliničkih istraživanja za sve ispitivane indikacije, u kojima je liječeno s levetiracetamom ukupno 3416 bolesnika.
English: However subjects, who took levetiracetam in the long-term open label follow-up study, did not experience a worsening, on average, in their behavioural and emotional functioning; in particular measures of aggressive behaviour were not worse than baseline.
Croatian: Međutim, u ispitanika koji su uzimali levetiracetam tijekom dugoročne, otvorene studije provedene praćenjem u prosjeku nije bilo pogoršanja bihevioralnog i emocionalnog funkcioniranja; osobito nije bilo pogoršanja pokazatelja agresivnog ponašanja u odnosu na početno stanje.
English: 500 to 1,500 mg twice daily 500 to 1,000 mg twice daily 250 to 750 mg twice daily 250 to 500 mg twice daily 500 to 1,000 mg once daily (2)
Croatian: 500 do 1500 mg dva puta na dan 500 do 1000 mg dva puta na dan 250 do 750 mg dva puta na dan 250 do 500 mg dva puta na dan 500 do 1000 mg jedanput na dan (2)
English: At the beginning of the treatment or at dose increase side effects like sleepiness, tiredness and dizziness may be more common.
Croatian: Na početku liječenja ili nakon povećanja doze nuspojave kao što su pospanost, umor i omaglica mogu se javiti češće.
English: If you take more Levetiracetam ratiopharm than you should
Croatian: Ako uzmete više Levetiracetama ratiopharm nego što ste trebali
English: Clear liquid.
Croatian: Bistra tekućina.
English: • Close the bottle with the plastic screw cap after every usage.
Croatian: • Nakon svake upotrebe zatvorite bočicu plastičnim zatvaračem.
English: When you will first start taking Levetiracetam ratiopharm, your doctor will prescribe you a lower dose (500 mg each day) during 2 weeks before giving you the lowest general dose of 1000 mg.
Croatian: Kad prvi put počnete uzimati Levetiracetam ratiopharm, liječnik će Vam propisati manju dozu (500 mg svakog dana) tijekom 2 tjedna prije davanja najmanje uobičajene doze od 1000 mg.
English: In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 125 mg.
Croatian: Ujedno, dostupne doze tableta nisu prikladne za početak liječenja u djece lakše od 25 kg, u bolesnika koji ne mogu gutati tablete ili za davanje doza manjih od 125 mg.
English: General dose: between 1000 mg and 3,000 mg each day.
Croatian: Uobičajena doza: između 1000 mg i 3000 mg svaki dan.
English: This medicine contains 1.2 mmol (or 46.65 mg) potassium per 15 ml.
Croatian: Ovaj lijek sadrži 1,2 mmol (ili 46,65 mg) kalija na 15 ml.
English: Contents of the pack and other information What Levetiracetam ratiopharm contains
Croatian: Sadržaj pakiranja i druge informacije Što Levetiracetam ratiopharm sadrži
English: How to store Levetiracetam ratiopharm Contents of the pack and other information
Croatian: Kako čuvati Levetiracetam ratiopharm Sadržaj pakiranja i druge informacije
English: In anuric end-stage renal disease adult subjects the half-life was approximately 25 and 3.1 hours during interdialytic and intradialytic periods, respectively.
Croatian: U odraslih bolesnika u anuričnoj krajnjoj fazi bubrežne bolesti poluvijek iznosi približno 25 i 3,1 sati u razdoblju između dijalize, odnosno tijekom dijalize.
English: In infants and children aged 1 month to less than 4 years, irritability (very common, 11.7 %) and coordination abnormal (common, 3.3 %) were reported more frequently than in other age groups or in the overall safety profile.
Croatian: U dojenčadi i djece u dobi od 1 mjseca do manje od 4 godine, razdražljivost (vrlo često, 11,7%) i poremećaji koordinacije (često, 3,3%) bili su prijavljeni češće nego u drugim dobnim skupinama ili u cjelokupnom sigurnosnom profilu.
English: Adverse effects not observed in clinical studies but seen in the rat and to a lesser extent in the mouse at exposure levels similar to human exposure levels and with possible relevance for clinical use were liver changes, indicating an adaptive response such as increased weight and centrilobular hypertrophy, fatty infiltration and increased liver enzymes in plasma.
Croatian: Štetni učinci s mogućim značajem za kliničku primjenu koji nisu primijećeni tijekom kliničkih studija, a koji su nađeni kod štakora i u manjoj mjeri kod miševa izloženih razinama sličnim razinama izloženosti kod ljudi, bili su promjene jetre koje su upućivale na prilagodbeni odgovor kao na primjer povećana težina i centrilobularna hipertrofija, masna infiltracija jetre i povišene razine jetrenih enzima u plazmi.
English: In order to ensure the accuracy of the dosing this presentation should be prescribed for infants and young children aged from 6 months to less than 4 years.
Croatian: Kako bi se osiguralo točno doziranje to pakiranje treba propisivati dojenčadi i maloj djeci u dobi od 6 mjeseci do manje od 4 godine.
English: Adverse reactions are presented in the order of decreasing seriousness and their frequency is defined as follows: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon
Croatian: Nuspojave su prikazane u padajućem nizu s obzirom na ozbiljnost i njihova je učestalost definirana na sljedeći način: vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000) i vrlo rijetko (<1/10 000).
English: The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Croatian: Djelatna tvar, levetiracetam, jest derivat pirolidona (S-enantiomer α-etil-2-okso-1-pirolidin acetamida), kemijski različit od postojećih antiepileptičkih djelatnih tvari.
English: Levetiracetam ratiopharm is indicated as adjunctive therapy
Croatian: Levetiracetam ratiopharm je indiciran kao dodatna terapija
English: In a study reflecting clinical practice, the concomitant antiepileptic medication could be withdrawn in a limited number of patients who responded to levetiracetam adjunctive therapy (36 adult patients out of 69).
Croatian: U studiji koja je bila odraz kliničke prakse bilo je moguće prekinuti istodobno antiepileptičko liječenje u ograničenog broja bolesnika koji su odgovorili na dodatno liječenje levetiracetamom (36 od 69
English: Levetiracetam ratiopharm is used:
Croatian: Levetiracetam ratiopharm se koristi:
English: Alopecia, eczema, pruritus,
Croatian: Alopecija, ekcem, pruritis,
English: Talk to your doctor before taking Levetiracetam ratiopharm
Croatian: Obratite se svom liječniku prije nego uzmete Levetiracetam ratiopharm
English: 233 of these patients were treated with levetiracetam in placebo-controlled studies.
Croatian: 233 od tih bolesnika bilo je liječeno s levetiracetamom u placebom kontroliranim ispitivanjima.
English: At 3600 mg/kg/day, in only one of the 2 EFD studies, there was a slight decrease in foetal weight associated with a marginal increase in skeletal variations/minor anomalies.
Croatian: Pri dozi od 3600 mg/kg/dan samo je u jednoj od dvije EFR studije uočeno blago smanjenje fetalne težine povezano s marginalnim porastom varijacija kostura/malih anomalija.
English: EXP Do not use after 4 months of first opening the bottle.
Croatian: EXP Nemojte primjenjivati nakon isteka 4 mjeseca od prvog otvaranja boce.
English: In a pooled analysis, the percentage of patients who achieved 50 % or greater reduction from baseline in the partial onset seizure frequency per week at stable dose (12/14 weeks) was of 27.7 %, 31.6 % and 41.3 % for patients on 1000, 2000 or 3000 mg levetiracetam respectively and of 12.6 % for patients on placebo.
Croatian: Analizom zbirnih podataka utvrđeno je da je postotak bolesnika kod kojih je postignuto 50 %-tno ili više smanjenje od početne učestalosti djelomičnih napadaja tjedno uz konstantnu dozu (12/14 tjedana) bio 27,7% kod uzetih 1000 mg, 31,6% kod uzetih 2000 mg i 41,3% kod uzetih 3000 mg levetiracetama te 12,6% kod uzimanja placeba.
English: For children aged 6 months to less than 4 years.
Croatian: Za djecu u dobi od 6 mjeseci do manje od 4 godine.
English: Swallow Levetiracetam ratiopharm film-coated tablets with a sufficient quantity of liquid (e.g. a glass of water).
Croatian: Progutajte Levetiracetam ratiopharm filmom obložene tablete s dovoljnom količinom tekućine (npr. s čašom vode).
English: What Levetiracetam ratiopharm looks like and contents of the pack
Croatian: Kako Levetiracetam ratiopharm izgleda i sadržaj pakiranja
English: Sixty of these patients were treated with levetiracetam in placebo-controlled studies.
Croatian: Šezdeset od tih bolesnika bilo je liječeno s levetiracetamom u placebom kontroliranim ispitivanjima.
English: Levetiracetam has minor or moderate influence on the ability to drive and use machines.
Croatian: Levetiracetam malo ili umjereno utječe na sposobnost upravljanja vozilima i strojevima.
English: Film-coated tablet Multipack: 200 (2 packs of 100) film-coated tablets
Croatian: Filmom obložena tableta Višestruko pakiranje: 200 (2 pakiranja od 100) filmom obloženih tableta
English: If levetiracetam has to be discontinued it is recommended to withdraw it gradually (e.g. in adults and adolescents weighing more than 50 kg: 500 mg decreases twice daily every two to four weeks; in infants older than 6 months, children and adolescents weighting less than 50 kg: dose decrease should not exceed 10 mg/kg twice daily every two weeks; in infants (less than 6 months): dose decrease should not exceed 7 mg/ kg twice daily every two weeks).
Croatian: Ako treba prekinuti liječenje levetiracetamom, preporučuje se postupni prekid (npr. u odraslih i adolescenata teških 50 kg ili više: smanjenje za 500 mg dva puta na dan svaka dva do četiri tjedna; u dojenčadi starije od 6 mjeseci, djece i adolescenata teških manje od 50 kg: smanjenje doze za ne više od 10 mg/kg dva puta na dan svaka dva tjedna; u dojenčadi (mlađe od 6 mjeseci): doza se ne smije smanjivati za više od 7 mg/kg dva puta na dan svaka dva tjedna).
English: In the population pharmacokinetic analysis conducted in patients from 1 month to 16 years of age, body weight was significantly correlated to apparent clearance (clearance increased with an increase in body weight) and apparent volume of distribution.
Croatian: Farmakokinetička analiza populacije obavljena u bolesnika u dobi od 1 mjeseca do 16. godine života pokazala je značajnu korelaciju tjelesne težine s prividnim klirensom (klirens se povećavao s porastom tjelesne težine) i s prividnim volumenom distribucije.
English: Germany e-mail: info@ratiopharm.de
Croatian: Njemačka e-mail: info@ratiopharm.de
English: Your doctor will prescribe the most appropriate pharmaceutical form of Levetiracetam ratiopharm according to the age, weight and dose.
Croatian: Liječnik će propisati najprikladniji farmaceutski oblik Levetiracetama ratiopharm sukladno dobi, tjelesnoj težini i dozi.
English: The dose level of 1800 mg/kg/day induced a marked maternal toxicity and a decrease in foetal weight associated with increased incidence of fetuses with cardiovascular/skeletal anomalies.
Croatian: Doza od 1800 mg/kg/dan izazvala je znatnu maternalnu toksičnost i smanjenje fetalne težine, povezane s povećanom pojavnošću fetusa s anomalijama srčano-žilnog sustava i kostura.
English: 58.3 % of the levetiracetam treated patients and 23.3 % of the patients on placebo had at least a 50 % reduction in myoclonic seizure days per week.
Croatian: 58,3% bolesnika liječenih levetiracetamom i 23,3% bolesnika koji su dobivali placebo imalo je barem 50 %-tno smanjenje broja dana s miokloničkim napadajima tjedno.
English: If stopping treatment, Levetiracetam ratiopharm should be discontinued gradually to avoid an increase of seizures.
Croatian: Ako prekidate liječenje Levetiracetamom ratiopharm, prekid mora biti postupan kako bi se izbjeglo pojačanje napadaja.
English: In this study, levetiracetam dose was 3000 mg/day for adults and adolescents or 60 mg/kg/day for children, given in 2 divided doses.
Croatian: Doza levetiracetama u toj studiji bila je 3000 mg na dan za odrasle i adolescente a za djecu 60 mg/kg/dan, podjeljeno na dvije doze.
English: Grape flavour Citric acid monohydrate Sodium hydroxide Purified water
Croatian: aroma grožđa citratna kiselina hidrat natrijev hidroksid voda, pročišćena
English: Film-coating:
Croatian: Film-ovojnica:
English: It was concluded that levetiracetam was not different (non inferior) from placebo with regard to the change from baseline of the Leiter-R Attention and Memory, Memory Screen Composite score in the per-protocol population.
Croatian: Zaključeno je da se levetiracetam u populaciji po protokolu nije razlikovala od placeba (nije bio inferioran) s obzirom na promjene od početnih vrijednosti rezultata testiranja dobivenih ljestvicom Leiter-R Attention and Memory, Memory Screen Composite.
English: Other medicines and Levetiracetam ratiopharm
Croatian: Drugi lijekovi i Levetiracetam ratiopharm
English: • Levetiracetam ratiopharm is used as a chronic treatment.
Croatian: • Levetiracetam ratiopharm se koristi za dugotrajno liječenje.
English: Oral solution.
Croatian: ovisno o odgovoru.
English: Each ml contains 1.4 mg methyl parahydroxybenzoate (E 218), 0.27 mg propyl parahydroxybenzoate (E 216) and 3.1 mg potassium.
Croatian: Jedan ml sadrži 1,4 mg metilparahidroksibenzoata (E218), 0,27 mg propilparahidroksibenzoata (E216) i 3,1 mg kalija.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer wrapper label on multipacks wrapped in transparent foil - including the Blue Box
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Naljepnica na višestrukom pakiranju omotanom u prozirnu foliju - uključujući plavi okvir
English: In patients aged 1 month to less than 4 years, a total of 190 patients have been treated with levetiracetam in placebo-controlled and open label extension studies.
Croatian: U bolesnika u dobi od 1 mjeseca do manje od 4 godine, ukupno 190 bolesnika liječeno je s levetiracetamom u placebom kontroliranim i ispitivanjima otvorenog produžetka.
English: Multipack: 200 (2 packs of 100) film-coated tablets Multipack: 120 (2 packs of 60) film-coated tablets
Croatian: Višestruko pakiranje: 200 (2 pakiranja od 100) filmom obloženih tableta Višestruko pakiranje: 120 (2 pakiranja od 60) filmom obloženih tableta
English: In patients aged 4-16 years, a total of 645 patients have been treated with levetiracetam in placebo-controlled and open label extension studies.
Croatian: U bolesnika u dobi 4-16 godina, ukupno 645 bolesnika liječeno je s levetiracetamom u placebom kontroliranim i ispitivanjima otvorenog produžetka.
English: CLcr (ml/min) = ----------------------------------------- (x 0.85 for women) 72 x serum creatinine (mg/dl)
Croatian: CLcr (ml/min) = --------------------------------------------- (x 0,85 za žene) 72 x kreatinin u serumu (mg/dl)
English: The oral solution is the formulation to use in infants.
Croatian: Oralna otopina je oblik za primjenu kod dojenčadi.
English: Contact your doctor if you took more Levetiracetam ratiopharm than you should.
Croatian: Obavijestite liječnika ako ste uzeli veću količinu Levetiracetama ratiopharm nego što ste trebali.
English: Levetiracetam ratiopharm 100 mg/ml oral solution is a formulation more appropriate to infants and children under the age of 6 years and to children and adolescent (from 6 to 17 years) weighing less than 50 kg and when tablets don't allow accurate dosage.
Croatian: Levetiracetam ratiopharm 100 mg/ml oralna otopina je prikladniji farmaceutski oblik za primjenu u dojenčadi i djece mlađe od 6 godina, djece i adolescenata (6-17 godina) tjelesne težine manje od 50 kg te kada se tabletama ne može postići točno doziranje.
English: Pre-marketing data from clinical studies conducted in adults indicate that levetiracetam did not influence the serum concentrations of existing antiepileptic medicinal products (phenytoin, carbamazepine, valproic acid, phenobarbital, lamotrigine, gabapentin and primidone) and that these antiepileptic medicinal products did not influence the pharmacokinetics of levetiracetam.
Croatian: Rezultati kliničkih studija na odraslim bolesnicima prije stavljanja lijeka u promet pokazuju da levetiracetam ne utječe na serumske koncentracije postojećih antiepileptika (fenitoin, karbamazepin, valproična kiselina, fenobarbital, lamotrigin, gabapentin i primidon) te da ti antiepileptici ne utječu na farmakokinetiku levetiracetam.
English: The patients were randomized to carbamazepine CR 400 - 1200 mg/day or levetiracetam 1000 - 3000 mg/day, the duration of the treatment was up to 121 weeks depending on the response.
Croatian: Bolesnici su randomizirani za dobivanje 400 -1200 mg karbamazepina s kontroliranim otpuštanjem (CR) na dan ili 1000 - 3000 mg levetiracetama na dan, liječenje je trajalo do 121 tjedna, ovisno o odgovoru.
English: Two embryo-foetal development (EFD) studies were performed in rats at 400, 1200 and 3600 mg/kg/day.
Croatian: Provedene su dvije studije embrio-fetalnog razvoja (EFR) u štakora s dozama od 400, 1200 i 3600 mg/kg/dan.
English: Dose and frequency (1) Infants 1 to less than 6 months
Croatian: Doza i učestalost primjene (1) Dojenčad od 1 do manje od 6
English: You should continue Levetiracetam ratiopharm treatment for as long as your doctor has told you.
Croatian: Levetiracetamom ratiopharm onoliko dugo koliko je liječnik odredio.
English: Do not use this medicine after the expiry date stated on the cardboard box and bottle after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i boci iza oznake „EXP“.
English: In children and adolescents aged 4 to 16 years, vomiting (very common, 11.2 %), agitation (common, 3.4%), mood swings (common, 2.1 %), affect lability (common, 1.7 %), aggression (common, 8.2 %), abnormal behaviour (common, 5.6 %), and lethargy (common, 3.9 %) were reported more frequently than in other age ranges or in the overall safety profile.
Croatian: U djece i adolescenata u dobi 4 do 16 godina povraćanje (vrlo često, 11,2%), agitacija (često, 3,4%), promjene raspoloženja (često, 2,1%), labilnost afekta (često, 1,7%), agresija (često, 8,2%), poremećaj ponašanja (često, 5,6%) i letargija (često, 3,9%) bili su prijavljeni češće nego u drugim dobnim rasponima ili u cjelokupnom sigurnosnom profilu.
English: Contains methyl and propyl parahydroxybenzoate and potassium.
Croatian: Sadrži metil- i propilparahidroksibenzoat i kalij.
English: This medicine contains less than 1 mmol sodium (23 mg) per 15 ml that is to say essentially ‘sodiumfree'.
Croatian: Ovaj lijek sadrži manje od 1 mmol (23 mg) natrija po 15 ml, tj. zanemarive količine natrija.
English: Peak concentrations (Cmax) are typically 31 and 43 μg/ml following a single 1,000 mg dose and repeated 1,000 mg twice daily dose, respectively.
Croatian: Vršna koncentracija (Cmax) uglavnom je 31 μg/ml nakon jedne doze od 1,000 mg i 43 μg/ml nakon ponovljene doze od 1,000 mg dva puta na dan.
English: Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol, Talc, Blue indigo carmine aluminium lake (E132)
Croatian: Poli(vinilni alkohol), titanijev dioksid (E171), makrogol, talk, blue indigo carmine aluminium lake (E132).
English: Dosing adjustment for adult and adolescents patients weighing more than 50 kg with impaired renal function:
Croatian: Prilagođavanje doze za odrasle bolesnike i adolescente teške više od 50 kg s oštećenom bubrežnom funkcijom: Skupina
English: • Open the bottle: press the cap and turn it anticlockwise.
Croatian: • Otvorite bočicu: pritisnite zatvarač i okrenite ga suprotno od smjera kazaljke na satu.